Sign In

Prevention of HIV.

HIV Question Bank

Preventing Perinatal HIV TransmissionQuestion 4/15

Questions in Topic

A 26-year-old cisgender woman tested positive for HIV 4 days ago at the time of a first prenatal visit. She is at approximately 18 weeks’ gestation. Her initial laboratory studies showed a CD4 count of 380 cells/mm3, an HIV RNA of 14,470 copies/mL, normal renal function, and a negative HLA-B*5701 test. She has never received antiretroviral therapy, and results from the baseline genotype resistance assay are pending.

Which one of the following would is considered a preferred nucleoside reverse transcriptase inhibitor (NRTI) backbone option in this situation?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
June 7th, 2024

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.